Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Surveillance of rVSV-ZEBOV Vaccine-induced Immunity Against Ebola Virus in Previously Vaccinated Health Care Workers < EBOSURV >

NCT05313139 is registered in ClinicalTrials.gov with Institute of Tropical Medicine, Belgium as lead sponsor.

NCT NCT05313139
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05313139 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Surveillance of rVSV-ZEBOV Vaccine-induced Immunity Against Ebola Virus in Previously Vaccinated Health Care Workers < EBOSURV >
Lead sponsor
Institute of Tropical Medicine, Belgium
Phase
Observational
Overall status
Completed
Start date
December 13, 2021
Completion date
March 3, 2025
Enrollment
133 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

immune response